Stock Information
Amgen Inc (AMGN)
Ticker Symbol: AMGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $187,358.96 mil
Piotroski score: 7
PE Ratio: 24.4674
EPS (TTM): 14.2333
Revenue (TTM): $67.68 M
Dividend Yield: 2.8947217276434%
ROE: 96.65%
Latest News
-
2 Dow Jones Stocks with Exciting Potential and 1 Facing Headwinds
Thu, Apr 16, 2026 7:30 PM
-
OpenAI launches AI model GPT-Rosalind for life sciences research
Thu, Apr 16, 2026 6:16 PM
-
Thyroid Eye Disease Treatment Market Research Report 2026 Featuring Amgen, Viridian, Novartis, Roche, Sanofi, AbbVie, and Teva with Analyst Recommendations and Forecasts to 2031
Thu, Apr 16, 2026 3:24 PM
-
J&J Targets Double-Digit Growth by 2030 Despite Stelara Drag
Thu, Apr 16, 2026 1:42 PM
-
Greywolf Therapeutics appoints Edwin Moses as Chair
Thu, Apr 16, 2026 6:00 AM
-
2 Reasons to Like AMGN and 1 to Stay Skeptical
Wed, Apr 15, 2026 5:46 PM
-
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Wed, Apr 15, 2026 5:16 PM
-
Protalix: Elfabrio Struggles Against Oral Competition
Wed, Apr 15, 2026 2:47 PM
-
Amgen And Zai Lab Trial Tests DLL3 Combo As Valuation Looks Undemanding
Tue, Apr 14, 2026 5:03 PM
-
J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook
Tue, Apr 14, 2026 4:28 PM
Key Financials
Financial data not available
